Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
- Division of Psychological and Social Medicine and Developmental Neurosciences
- University of Oslo
- deCODE Genetics
- Keck School of Medicine at University of Southern California
- Johnson & Johnson
- University of Lausanne
- Vrije Universiteit Amsterdam (VU)
- Amsterdam University Medical Centers (UMC)
- National Ageing Research Institute
- University of Melbourne
- Heinrich Heine University Düsseldorf
- JARA-Brain Institute I Brain structure function relationships
- Umeå University
- Murdoch University
- University of Toronto
- University of Texas Rio Grande Valley School of Medicine
- Radboud University Nijmegen
- University of Bergen
- Haukeland universitetssjukehus
- University of New South Wales
- Utrecht University
- University of Greifswald
- University of New Mexico
- Royal College of Surgeons in Ireland
- University of California at San Diego
- University of Basel
- King's College London (KCL)
- Trinity College Dublin
- Hospital Universitario Marques de Valdecilla
- CIBER - Center for Biomedical Research Network
- University of Cape Town
- South London and Maudsley NHS Foundation Trust
- Queensland University of Technology
- University of California at Davis
- University of Galway
- Massachusetts General Hospital
- Athinoula A. Martinos Center for Biomedical Imaging
- National Institutes of Natural Sciences - National Institute for Physiological Sciences
- Yale University
- Institute of Living
- Humboldt University of Berlin
- University of Stellenbosch
- Charité – Universitätsmedizin Berlin
Abstract
Carriers of large recurrent copy number variants (CNVs) have a higher risk of developing neurodevelopmental disorders. The 16p11.2 distal CNV predisposes carriers to e.g., autism spectrum disorder and schizophrenia. We compared subcortical brain volumes of 12 16p11.2 distal deletion and 12 duplication carriers to 6882 non-carriers from the large-scale brain Magnetic Resonance Imaging collaboration, ENIGMA-CNV. After stringent CNV calling procedures, and standardized FreeSurfer image analysis, we found negative dose-response associations with copy number on intracranial volume and on regional caudate, pallidum and putamen volumes (β = −0.71 to −1.37; P < 0.0005). In an independent sample, consistent results were obtained, with significant effects in the pallidum (β = −0.95, P = 0.0042). The two data sets combined showed significant negative dose-response for the accumbens, caudate, pallidum, putamen and ICV (P = 0.0032, 8.9 × 10−6, 1.7 × 10− 9, 3.5 × 10−12 and 1.0 × 10−4, respectively). Full scale IQ was lower in both deletion and duplication carriers compared to non-carriers. This is the first brain MRI study of the impact of the 16p11.2 distal CNV, and we demonstrate a specific effect on subcortical brain structures, suggesting a neuropathological pattern underlying the neurodevelopmental syndromes.
Details
Original language | English |
---|---|
Pages (from-to) | 584-602 |
Number of pages | 19 |
Journal | Molecular psychiatry |
Volume | 25 |
Issue number | 3 |
Publication status | Published - 1 Mar 2020 |
Peer-reviewed | Yes |
External IDs
PubMed | 30283035 |
---|---|
ORCID | /0000-0003-2132-4445/work/160950896 |
ORCID | /0000-0002-1753-7811/work/160953377 |